Literature DB >> 16548893

The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology.

Panagiotis Papatheodorou1, Grazyna Domańska, Marius Oxle, Johannes Mathieu, Olaf Selchow, Brendan Kenny, Joachim Rassow.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is a human intestinal pathogen and a major cause of diarrhoea, particularly among infants in developing countries. EPEC target the Map and EspF multifunctional effector proteins to host mitochondria - organelles that play crucial roles in regulating cellular processes such as programmed cell death (apoptosis). While both molecules interfere with the organelles ability to maintain a membrane potential, EspF plays the predominant role and is responsible for triggering cell death. To learn more about the Map-mitochondria interaction, we studied Map localization to mitochondria with purified mitochondria (from mammalian and yeast cells) and within intact yeast. This revealed that (i) Map targeting is dependent on the predicted N-terminal mitochondrial targeting sequence, (ii) the N-terminal 44 residues are sufficient to target proteins to mitochondria and (iii) Map import involves the mitochondrial outer membrane translocase (Tom22 and Tom40), the mitochondrial membrane potential, and the matrix chaperone, mtHsp70. These results are consistent with Map import into the mitochondria matrix via the classical import mechanism. As all known, Map-associated phenotypes in mammalian cells are independent of mitochondrial targeting, this may indicate that import serves as a mechanism to remove Map from the cytoplasm thereby regulating cytoplasmic function. Intriguingly, Map, but not EspF, alters mitochondrial morphology with deletion analysis revealing important roles for residues 101-152. Changes in mitochondrial morphology have been linked to alterations in the ability of these organelles to regulate cellular processes providing a possible additional role for Map import into mitochondria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548893     DOI: 10.1111/j.1462-5822.2005.00660.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  32 in total

1.  The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Authors:  Stephanie R Shames; Matthew A Croxen; Wanyin Deng; B Brett Finlay
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 2.  Interactions between bacterial pathogens and mitochondrial cell death pathways.

Authors:  Thomas Rudel; Oliver Kepp; Vera Kozjak-Pavlovic
Journal:  Nat Rev Microbiol       Date:  2010-09-06       Impact factor: 60.633

3.  Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.

Authors:  Anand Prakash Singh; Saima Aijaz
Journal:  Bioengineered       Date:  2015-10-02       Impact factor: 3.269

Review 4.  Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy.

Authors:  Pedro Escoll; Sonia Mondino; Monica Rolando; Carmen Buchrieser
Journal:  Nat Rev Microbiol       Date:  2015-11-23       Impact factor: 60.633

5.  A phosphodiesterase 2A isoform localized to mitochondria regulates respiration.

Authors:  Rebeca Acin-Perez; Michael Russwurm; Kathrin Günnewig; Melanie Gertz; Georg Zoidl; Lavoisier Ramos; Jochen Buck; Lonny R Levin; Joachim Rassow; Giovanni Manfredi; Clemens Steegborn
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

6.  Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo.

Authors:  Mai Nguyen; Jason Rizvi; Gail Hecht
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

7.  Virulence-Related Genes and Coenteropathogens Associated with Clinical Outcomes of Enteropathogenic Escherichia coli Infections in Children from the Brazilian Semiarid Region: a Case-Control Study of Diarrhea.

Authors:  Ana Karolina S Santos; Pedro Henrique Q S de Medeiros; Mariana D Bona; Mara M G Prata; Marília S M G Amaral; Herlice N Veras; Rafaela C Pankov; Samilly A Ribeiro; Paloma A Cavalcante; Thiago M Freitas; Rafhaella D G Gondim; Daniel M N de Oliveira; Natália K F M Melo; Alexandre Havt; Aldo A M Lima
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

8.  NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.

Authors:  Cordula Hemrajani; Cedric N Berger; Keith S Robinson; Olivier Marchès; Aurelie Mousnier; Gad Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

Review 9.  Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Authors:  Stuart W Hicks; Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2013-05       Impact factor: 60.633

10.  Identification of a mammalian-type phosphatidylglycerophosphate phosphatase in the Eubacterium Rhodopirellula baltica.

Authors:  Phildrich G Teh; Mark J Chen; James L Engel; Carolyn A Worby; Gerard Manning; Jack E Dixon; Ji Zhang
Journal:  J Biol Chem       Date:  2013-01-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.